SEPTInvestingStart Free

MEDS 10-Q: SEC filing

DataMeds AI, Inc.

Filed with the SEC on · accession 0001493152-26-051830

MEDS filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -14.5% by the first close after the filing.

Summary of the filing

DataMeds AI, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and operational updates.

For details, click here →How to read a 10-Q →

Key details

FilerDataMeds AI, Inc.
Subsidiary/affiliateHealthstar Technologies LLC
Subsidiary/affiliateKareRx Hub LLC
Subsidiary/affiliateKare Pharmtech LLC

How MEDS stock reacted

Close before

$0.87

Nov 12, 2026

First close after

-14.51%

$0.74

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MEDS?

Click here

Frequently asked questions

What did MEDS file with the SEC on Nov 13, 2026?

MEDS filed a 10-Q (SEC filing). DataMeds AI, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and operational updates.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did MEDS stock react to this filing?

MEDS closed at $0.87 before the filing and $0.74 on Nov 13, 2026 (-14.51%).

Other MEDS SEC filings

Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MEDS overviewMEDS analysisMEDS newsLatest SEC filings